There are 11,099 papers on dementia in aging research: 584 trials and 7,156 observational studies in people, 90 in animals, 5 in cells, 2,675 reviews. The newest story, Nov 16, 2026: “Blood marker and age linked to risk of cognitive impairment”.
“aspirin allocation was associated with a 3.5-fold reduction in incident dementia versus placebo (hazard ratio [HR]: 0.28, 95% confidence interval [CI]: 0.15 to 0.52)”
Hearing aids showed no clear effect on dementia in humans (RR, 0.59; 95% CI, 0.25-1.38).
“As the primary outcome, the 24-month incidence of conversion from MCI to dementia-level impairment did not differ significantly between the intervention group (3.09%; 95% CI, 1.62%-5.74%) and the control group (4.74%; 95% CI, 2.60%-8.29%; RD, −2.07%, 95% CI, −4.74% to 0.61%; RR, 0.59; 95% CI, 0.25-1.38; P =.23”
Hearing aids showed no clear effect on dementia in humans (mild cognitive impairment and moderate to severe hearing loss) (RR 0.59 (95% CI, 0.25-1.38)).
“No significant difference was observed in the primary outcome, in which the conversion rate from MCI to dementia-level impairment was 3.09% (95% CI, 1.62%-5.74%) in the intervention group vs 4.74%”
Human trialmild cognitive impairment and moderate to severe hearing loss24 monthsn = 703
Spousal traumatic brain injury was not clearly linked with dementia in humans (Uninjured spouses; compared with no spousal traumatic brain injury) (HR 1.17, 95% CI 0.88–1.56).
“but not dementia (HR, 1.17 [95% CI, 0.88-1.56]; P = .28) or MACE (HR, 1.15 [95% CI, 0.84-1.57]; P = .40).”
HumansUninjured spouses; compared with no spousal traumatic brain injuryMedian follow-up 19.5 yearsn = 6,562
Bilateral salpingo-oophorectomy was not clearly linked with dementia in humans (Non-malignant hysterectomy; compared with ovarian conservation) (HR 0.90, 95% CI 0.65-1.24).
“BSO was not associated with cardiovascular disease, dementia, or osteoporosis-related fracture in women of postmenopausal age undergoing non-malignant hysterectomy.”
HumansNon-malignant hysterectomy; compared with ovarian conservationfemales
Dementia is linked with higher mortality in humans (proximal femur fracture undergoing surgery) (adjusted hazard ratio 1.95; 2-year mortality 62.4% vs 24.0%).
“Both mild and severe impairment were independently associated with increased mortality (adjusted hazard ratios 1.48 and 1.95, respectively).”
Dementia was not clearly linked with receipt of invasive coronary reperfusion therapy in humans (Acute coronary syndrome; patients with versus without dementia).
“No difference in the rate of invasive coronary reperfusion therapy was observed between the two groups.”
HumansAcute coronary syndrome; patients with versus without dementian = 212
Dementia is linked with lower 5-year survival in humans (dementia only) (49.2% vs 73.3% (US), 56.8% vs 77.5% (Mexico)).
“In the United States, standardized 5-year survival was 73.3% (no condition), 57.9% (diabetes only), 49.2% (dementia only), and 36.6% (dual conditions).”
The journals of gerontology. Series B, Psychological sciences and social sciences·
Functional recovery
↓downin humans1
1 study
Dementia is linked with worse functional recovery in humans (mortality 29-32%, home independence 23-52%, complete recovery 5-10% in dementia vs 6-11%, 84-86%, 21-22% without impairment).
“Younger-old and persons without preinjury cognitive impairment had substantially better recovery”
Dementia is linked with higher operational errors in humans (dementia) (p < 0.05).
“In contrast, the Dementia-D group showed widespread impairments, such as inconsistent pedal use, increased operational errors, and reduced intersection speeds (p < 0.05).”
Education, health behaviors, mental health, and cardiovascular health
→mediatesin humans1
1 study
education, health behaviors, mental health, and cardiovascular health is linked with dementia in humans (Joint mediation of the association between child abuse and dementia) (Approximately 18% of the association mediated; almost all mediation occurred through mental health).
“Education, health behaviours, mental health and cardiovascular health mediated approximately 18% of the association.”
HumansJoint mediation of the association between child abuse and dementian = 5,448
Mediterranean Diet Score was not clearly linked with dementia in humans.
“A higher MDS was associated with a lower risk of 20-year dementia morbidity in men (multivariable-adjusted HR=0.83; 95% CI: 0.71-0.96), but not in women.”
retirement timing was not clearly linked with dementia in humans (compared with individuals retiring after full-time work in early-to-mid 60s).
“Compared with individuals retiring after full-time work in their early-to-mid 60s, dementia risk was similar among those retiring earlier or later from full-time work.”
Humanscompared with individuals retiring after full-time work in early-to-mid 60sn = 13,879
Criteria-based probable REM sleep behavior disorder
↔no changein humans1HR 1
1 study
Criteria-based probable REM sleep behavior disorder was not clearly linked with dementia in humans (memory clinic cohort) (HR 1.00, 95% CI: 0.57–1.76).
“there was no association with all-cause dementia (HR 1.00, 95% CI: 0.57–1.76)”
Biological-age acceleration is linked with dementia in humans (childhood/adolescence smoking) (HR 1.0062, 95% CI 1.0002-1.0125; mediated proportion 3.63%).
“For childhood/adolescence smoking, the combined indirect effect through KDM-BA and PhenoAge acceleration was small (HR = 1.0062, 95% CI 1.0002-1.0125)”
GLP-1 receptor agonists are associated with dementia in humans (Adults without diabetes with BMI ≥27 kg/m2; compared with multivitamin use) (RR 0.17, 95% CI 0.15-0.19).
“GLP-1RA exposure was associated with substantially lower risks of dementia (RR 0.17, 95% CI 0.15-0.19)”
HumansAdults without diabetes with BMI ≥27 kg/m2; compared with multivitamin use10 yearsn = 57,066
GLP-1 receptor agonists are associated with dementia in humans (1.2% vs 1.6%; RR 0.75 (95% CI 0.57–0.98); HR 0.87 (95% CI 0.66–1.14), nonsignificant).
“GLP-1 RA initiation was associated with lower cumulative incidence of dementia compared with DPP-4i initiation (1.2% vs 1.6%; RR, 0.75;95% CI, 0.57-0.98; P=0.04).”
HumansType 2 diabetes after acute myocardial infarction; compared with DPP-4 inhibitor initiation within 180 days after myocardial infarction3 years
GLP-1 receptor agonists are linked with a lower risk of dementia in humans (compared with other second-line glucose-lowering medications) (HR 0.87; 2.8 fewer events/1000 person-years).
“dementia (HR = 0.87; 2.8 fewer)”
Humanscompared with other second-line glucose-lowering medications
GLP-1 receptor agonists are linked with a lower risk of dementia in humans (compared with DPP-4 inhibitor initiation, in COVID-19 survivors with type 2 diabetes) (HR 0.64 (95% CI 0.58–0.72)).
“GLP-1RA initiation was associated with a lower hazard of incident dementia (hazard ratio [HR], 0.64; 95% confidence interval [CI], 0.58-0.72)”
Humanscompared with DPP-4 inhibitor initiation, in COVID-19 survivors with type 2 diabetesup to 6 yearsn = 25,263
GLP-1 receptor agonists are linked with a lower risk of dementia in humans (versus long-acting insulin in type 2 diabetes) (HR 0.64, 95% CI 0.46-0.89).
“GLP-1 RA use was associated with significantly lower risk of overall dementia (HR 0.64, 95% CI 0.46-0.89, P=0.0072)”
Humansversus long-acting insulin in type 2 diabetesn = 10,783
GLP-1 receptor agonists are linked with a lower risk of dementia in medically managed idiopathic intracranial hypertension (HR 0.52, 95% CI 0.39-0.69).
“cognitive decline or dementia, 4.88% versus 8.17%, HR 0.52, 95% CI 0.39-0.69”
Alzheimer's & dementia : the journal of the Alzheimer's Association·
Dementia is associated with mortality in humans (sepsis survivors) (HR 1.304).
“Neoplasia (hazard ratio [HR], 2.011), liver cirrhosis (HR, 1.562), and dementia (HR, 1.304) were the comorbidities most strongly associated with mortality.”
Humanssepsis survivorswithin 2 years after hospital discharge
Dementia is associated with mortality in humans (compared with females of the same age without diagnosed dementia in Germany) (Up to 11 times higher risk of death).
“Females diagnosed with dementia had up to 11 times higher risk of death compared to those not diagnosed with dementia at the same age”
Humanscompared with females of the same age without diagnosed dementia in Germany2016–2021females
Dementia is linked with a higher risk of mortality in humans (patients with chronic limb-threatening ischemia undergoing distal bypass) (HR 1.79, 95% CI 1.24–2.59, P=0.002).
“dementia was independently associated with increased mortality (hazard ratio (HR), 1.79; 95% confidence interval (CI), 1.24–2.59, P=0.002)”
Humanspatients with chronic limb-threatening ischemia undergoing distal bypassn = 688
Dementia is associated with mortality in humans after hip fracture surgery.
“In the 1-year models, age, male sex, ASA IV status, dementia or cognitive impairment, and lower preoperative hemoglobin levels were independently associated with mortality.”
Dementia is associated with mortality in humans with comorbid sepsis (AAMR 30.8 per 100,000, AAPC 0.20%).
“Between 1999 and 2020, dementia with comorbid sepsis accounted for 284,645 deaths, yielding an overall AAMR of 30.8 (95% confidence interval: 30.7-30.9). Overall mortality remained stable (AAPC: 0.20%; 95% CI: -0.19 to 0.60).”
Dementia predicts mortality in adults with Down syndrome.
“The most influential predictors of mortality were any claim for dementia, any claim for pneumonia, re-occurring claim for cardiovascular disease three years before index death, and any claim for heart failure and epilepsy.”
Humansin adults with Down syndrome11 yearsn = 137,293
APOE is associated with dementia in humans (Total sample and people without HIV; rs429358 and rs769449) (rs429358: P = 8.8×10 –18; rs769449: P = 1.48 × 10 –12).
“Across total sample and people without HIV, three genome-wide significant single nucleotide polymorphisms (SNPs) were identified: rs429358 (gene: APOE , P = 8.8×10 –18 )”
HumansTotal sample and people without HIV; rs429358 and rs769449
APOE is linked with a higher risk of dementia in humans (poor profile with APOE ε4 carriers vs favorable-profile non-carriers) (HR 2.32, 95% CI 1.73-3.12).
“Relative to favorable-profile APOE ε4 non-carriers, dementia risk was highest among participants with a poor profile who were APOE ε4 carriers (HR 2.32, 95% CI 1.73-3.12).”
Humanspoor profile with APOE ε4 carriers vs favorable-profile non-carriers31-year58% femalesn = 14,333
medRxiv : the preprint server for health sciences·Preprint
APOE is associated with dementia in humans (exploratory analyses).
“In exploratory analyses, apolipoprotein E ε4 genotype, thoracic aortic calcium, and plasma neurofilament light chain were associated with incident dementia”
Humansexploratory analysesmedian of 4.7 yearsn = 730
Type 2 diabetes is associated with dementia in humans Following type 2 diabetes diagnosis; compared with individuals without diabetes (1-year cumulative incidence: 0.55% versus 0.40%; 5-year: 2.20% versus 2.05%).
“The absolute risk of dementia was initially higher among patients with T2D.”
HumansFollowing type 2 diabetes diagnosis; compared with individuals without diabetes1 and 5 years
“Vascular conditions, traumatic brain injury, post-traumatic stress disorder, and depression were associated with risk of dementia among AI/AN veterans.”
Hearing loss is associated with dementia in humans (Pearson r = 0.827, Spearman rho = 0.845, p < 0.001).
“The global bivariate association between hearing loss prevalence and dementia prevalence was strong in females (Pearson r = 0.827; Spearman rho = 0.845; p < 0.001)”
Hearing loss raises the risk of dementia in humans (OR = 1.43, 95% CI: 1.21-1.68).
“Hearing loss was significantly associated with increased risk of cognitive impairment (OR = 1.34, 95% CI: 1.17-1.53) and dementia (OR = 1.43, 95% CI: 1.21-1.68).”
“Additional predictors included being born in the Southeastern U.S., lacking private health insurance, non-veteran status, having poor vision or hearing, limited work history, disability, diabetes, body mass index ≥ 35, prior stroke, and both alcohol abstention and heavy drinking.”
Diabetes mellitus is linked with a higher risk of dementia in humans (early-onset diabetes, high HbA1c, and high cholesterol levels) (HR 1.43, 95% CI 1.15-1.77).
“subgroup 3 of diabetes showed a significantly higher risk of dementia (hazard ratio [HR] 1.43, 95% confidence interval [CI] 1.15-1.77)”
Humansearly-onset diabetes, high HbA1c, and high cholesterol levels
Diabetes mellitus is linked with a higher risk of dementia in humans (OR 2.14, 95% CI 1.83-2.50).
“Compared to participants without diabetes, the dementia risk was significantly higher in participants with diabetes (Odds Ratio [OR]: 2.14, 95% Confidence Interval [CI]: 1.83-2.50)”
Lithium is linked with a lower risk of dementia in adults with bipolar disorder compared with valproate (HR 0.689, 95% CI 0.578-0.822; RR 0.658, 95% CI 0.556-0.778).
“Lithium use was associated with a lower risk of all-cause dementia than valproate use (207 [7.1%] vs 311 [10.8%]; Relative risk [RR], 0.658; 95% confidence interval [CI], 0.556-0.778; Hazard ratio [HR], 0.689; 95% CI, 0.578-0.822; both P<.001).”
Humansin adults with bipolar disorder compared with valproate
Aspirin lowers the risk of dementia in Q5 of the PGS distribution (highest quintile for genetically associated platelet count) (HR 0.29, 95% CI 0.16 to 0.55).
“aspirin use being associated with 3.5‐fold lower dementia risk versus placebo (HR: 0.29, 95% confidence interval [CI]: 0.16 to 0.55, p = 0.0001”
Human trialin Q5 of the PGS distribution (highest quintile for genetically associated platelet count)median follow‐up of 4.6 years
Alzheimer's & dementia : the journal of the Alzheimer's Association·
Aspirin lowers the risk of dementia in humans (highest quintile of platelet-count PGS003548) (HR 0.28, 95% CI 0.15-0.52).
“aspirin allocation was associated with a 3.5-fold reduction in incident dementia versus placebo (hazard ratio [HR]: 0.28, 95% confidence interval [CI]: 0.15 to 0.52)”
Human trialhighest quintile of platelet-count PGS003548
Metformin lowers the risk of dementia in humans (compared with placebo) (OR 0.40, 95% CI 0.17–0.97).
“randomization to metformin was associated with a 60% (OR 0.40 [95% confidence interval 0.17, 0.97]) and 62% (OR 0.38 [95% confidence interval 0.16, 0.89]) lower odds of dementia compared with placebo and ILS, respectively”
Human trialcompared with placeboaverage intervention duration of 3.2 yearsn = 1,483
medRxiv : the preprint server for health sciences·Preprint
Metformin lowers the risk of dementia in humans (compared with placebo) (60% lower odds (OR 0.40 [95%CI 0.17, 0.97])).
“randomization to metformin was associated with a 60% (OR 0.40 [95%CI 0.17, 0.97]) and 62% (OR 0.38 [95%CI 0.16, 0.89]) lower odds of dementia compared with placebo”
At age 75, estimated five-year risk of mild cognitive impairment was 17% with higher blood marker levels versus 7% with lower levels.At age 75, estimated five-year risk of mild cognitive impairment was 17% with higher blood marker levels versus 7% with lower levels.
Among 1,158 older adults at risk of dementia, 11 blood proteins were linked to differences in cognitive response to a lifestyle intervention.Among 1,158 older adults at risk of dementia, 11 blood proteins were linked to differences in cognitive response to a lifestyle intervention.